Information  X 
Enter a valid email address

Phorm Corporation (PHRM)


Monday 07 December, 2015

Phorm Corporation

Repricing of Options

RNS Number : 1306I
Phorm Corporation Limited
07 December 2015

7 December 2015


Phorm Corporation Limited

("Phorm" or the "Company")

Repricing of Options

Phorm (AIM: PHRM), a leading advertising-technology company and first party data platform provider, announces that, further to its announcement of 1 December 2015, Timothy Smith, Chief Executive Officer of the Company, has proposed an amendment to the price of the options granted to him pursuant to the Company's New Share Option Plan. Accordingly, Mr Smith now holds 49,083,988 options, which have an increased exercise price of 3.5 pence and will continue to vest as to one third on 29 January 2016 (being six months after his formal appointment as CEO on 29 July 2015) with the remainder vesting in eighteen equal monthly instalments thereafter. All other terms of Mr Smith's options remain unaltered.



For further information please contact: 

Phorm Corporation Limited

Timothy Smith (Chief Executive Officer)                                      +44 (0) 20 3397 6001


Mirabaud Securities LLP (Broker)                                           +44 (0) 20 7321 2508

Jason Woollard 

Peter Krens


Strand Hanson Limited (Nominated Adviser)                          +44 (0) 20 7409 3494

James Harris Matthew Chandler James Dance


About Phorm:

Phorm is a leading advertising-technology and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit:


This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t